Douglas David Schocken, MD

Professor of Medicine
Campus mail 6301 Herndon Rd., Room 505, Durham, NC 27713
Phone (919) 572-6061
Email address douglas.schocken@duke.edu
In Their Words

Education and Training

  • Fellow in Cardiology, Medicine, Duke University, 1978 - 1981
  • Resident, Medicine, Duke University, 1977 - 1978
  • Resident, Medicine, Duke University, 1974 - 1975
  • M.D., Duke University, 1974

Publications

Vesely, D. L., G. I. San Miguel, I. Hassan, W. R. Gower, and D. D. Schocken. “Atrial natriuretic hormone, vessel dilator, long-acting natriuretic hormone, and kaliuretic hormone decrease the circulating concentrations of total and tree T4 and free T3 with reciprocal increase in TSH.” J Clin Endocrinol Metab 86, no. 11 (November 2001): 5438–42. https://doi.org/10.1210/jcem.86.11.8039.

PMID
11701719
Full Text

Vesely, D. L., G. I. San Miguel, I. Hassan, and D. D. Schocken. “Atrial natriuretic hormone, vessel dilator, long-acting natriuretic hormone, and kaliuretic hormone decrease the circulating concentrations of CRH, corticotropin, and cortisol.” J Clin Endocrinol Metab 86, no. 9 (September 2001): 4244–49. https://doi.org/10.1210/jcem.86.9.7829.

PMID
11549655
Full Text

Nasser, A., J. R. Dietz, M. Siddique, H. Patel, N. Khan, E. K. Antwi, G. I. San Miguel, M. T. McCormick, D. D. Schocken, and D. L. Vesely. “Effects of kaliuretic peptide on sodium and water excretion in persons with congestive heart failure.” Am J Cardiol 88, no. 1 (July 1, 2001): 23–29. https://doi.org/10.1016/s0002-9149(01)01579-x.

PMID
11423053
Full Text

Vesely, D. L., G. I. Perez-Lamboy, and D. D. Schocken. “Long-acting natriuretic peptide, vessel dilator, and kaliuretic peptide enhance urinary excretion rate of albumin, total protein, and beta(2)-microglobulin in patients with congestive heart failure.” J Card Fail 7, no. 1 (March 2001): 55–63. https://doi.org/10.1054/jcaf.2001.23109.

PMID
11264551
Full Text

Vesely, D. L., G. I. Perez-Lamboy, and D. D. Schocken. “Long-acting natriuretic peptide, vessel dilator, and kaliuretic peptide enhance the urinary excretion rate of beta2-microglobulin.” Metabolism 49, no. 12 (December 2000): 1592–97. https://doi.org/10.1053/meta.2000.18557.

PMID
11145122
Full Text

Vesely, D. L., G. I. Perez-Lamboy, and D. D. Schocken. “Vessel dilator, long acting natriuretic peptide, and kaliuretic peptide increase circulating prostaglandin E2.” Life Sci 66, no. 10 (2000): 905–13. https://doi.org/10.1016/s0024-3205(99)00674-8.

PMID
10714891
Full Text

Vesely, D. L., J. R. Dietz, J. R. Parks, E. A. Antwi, R. M. Overton, M. T. McCormick, G. Cintron, and D. D. Schocken. “Comparison of vessel dilator and long-acting natriuretic peptide in the treatment of congestive heart failure.” Am Heart J 138, no. 4 Pt 1 (October 1999): 625–32. https://doi.org/10.1016/s0002-8703(99)70175-4.

PMID
10502206
Full Text

Malone, J. I., D. D. Schocken, A. D. Morrison, and E. Gilbert-Barness. “Diabetic cardiomyopathy and carnitine deficiency.” J Diabetes Complications 13, no. 2 (March 1999): 86–90. https://doi.org/10.1016/s1056-8727(99)00039-2.

PMID
10432172
Full Text

Daggubati, S., J. R. Parks, R. M. Overton, G. Cintron, D. D. Schocken, and D. L. Vesely. “Erratum: Adrenomedullin, endothelin, neuropeptide Y, atrial, brain and C-natriuretic prohormone peptides compared as early heart failure indicators (Cardiovascular Research 36 (1997) (246-255) PII: S0008636397001648).” Cardiovascular Research 44, no. 2 (January 1, 1999): 452–53. https://doi.org/10.1016/S0008-6363(99)00222-9.

Full Text

Pages